title: Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib.
authors.forename: Marek
authors.initials: M
authors.lastname: Hus
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Helbig
authors.forename: Maria
authors.initials: M
authors.lastname: Cioch
authors.forename: Hanna
authors.initials: H
authors.lastname: Szczepanska-Szerej
authors.forename: Paweł
authors.initials: P
authors.lastname: Wieczorek
authors.forename: Magdalena
authors.initials: M
authors.lastname: Woźniak
authors.forename: Justyna
authors.initials: J
authors.lastname: Kozinska
authors.forename: Marta
authors.initials: M
authors.lastname: Morawska
authors.forename: Anna
authors.initials: A
authors.lastname: Dmoszynska
authors.forename: Slawomira
authors.initials: S
authors.lastname: Kyrcz-Krzemien
authors.forename: Dariusz
authors.initials: D
authors.lastname: Kata
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002908:Chronic Disease; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D000068877:Imatinib Mesylate; D008279:Magnetic Resonance Imaging; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D011782:Quadriplegia / Q000188:drug therapy* / Q000209:etiology*; D012333:RNA, Messenger / Q000235:genetics; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; C479818:FIP1L1 protein, human; D010879:Piperazines; D011743:Pyrimidines; D012333:RNA, Messenger; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; D020796:Receptor, Platelet-Derived Growth Factor alpha